AlphaFold predicted structure
NEUROG3 · Q9Y4Z2

Mean pLDDT
69.0/ 100
Low
214 residues
Confidence breakdown
- Very high(≥ 90)31%
- Confident(70–90)7%
- Low(50–70)42%
- Very low(< 50)21%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
neurogenin 3
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Diabetes with additional phenotypes suggestive of a monogenic aetiology
BIALLELIC, autosomal or pseudoautosomalFamilial diabetes
BIALLELIC, autosomal or pseudoautosomalIntestinal failure or congenital diarrhoea
BIALLELIC, autosomal or pseudoautosomalNeonatal diabetes
BIALLELIC, autosomal or pseudoautosomalMonogenic diabetes
BIALLELIC, autosomal or pseudoautosomalMulti-organ autoimmune diabetes
BIALLELIC, autosomal or pseudoautosomalcongenital malabsorptive diarrhea 4
Congenital malabsorptive diarrhea due to paucity of enteroendocrine cells
neurodegenerative disease
type 2 diabetes mellitus
diabetes mellitus
permanent neonatal diabetes mellitus
Hirsutism
hereditary disease
diabetic retinopathy
Myelopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Neurogenin-3
Is a transcriptional regulator involved in the control of enteroendocrine cell differentiation (PubMed:21378176). Together with NKX2-2, initiates transcriptional activation of NEUROD1 (PubMed:16855267, PubMed:21378176). Involved in neurogenesis. Also required for the specification of a common precursor of the 4 pancreatic endocrine cell types (By similarity)
NEUROG3 · Q9Y4Z2

Mean pLDDT
69.0/ 100
Low
214 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0